J&J(US:JNJ) Globenewswire·2026-02-03 08:00Core Insights - Johnson & Johnson has launched ACUVUE® OASYS MAX 1-Day MULTIFOCAL for ASTIGMATISM, the first daily disposable multifocal toric contact lens for astigmatic presbyopes in the UK and Ireland, addressing the needs of a significant patient demographic [1][5] Product Features - The new lens provides exceptional comfort, clarity, and stability, offering clear vision at all distances and in various lighting conditions [4][1] - Clinical data indicates that nearly 91% of wearers were successfully fitted with their first pair of lenses during their initial visit [2][4] - The lens demonstrates 100% rotational stability within 5 degrees with a blink, and 95.3% of patients report clear vision during daily activities [4][2] Market Context - Astigmatism affects approximately half of patients in at least one eye, and up to 2.1 billion people globally are expected to develop presbyopia by 2030, highlighting a growing market for tailored vision solutions [1][4] - One in four astigmatic patients discontinue lens wear within the first year due to issues like blurred vision and discomfort, indicating a significant unmet need in this segment [1][4] Support for Eye Care Professionals - Johnson & Johnson has introduced tools such as the ACUVUE® simplifit calculator and the ACUVUE® Astigmatism Demonstration Flipper to assist Eye Care Professionals in providing personalized fitting experiences [2][3] - These tools aim to enhance efficiency and accuracy in identifying optimal trial lens power for patients, thereby improving patient care [2][3] Availability and Promotion - The ACUVUE® OASYS MAX 1-Day MULTIFOCAL for ASTIGMATISM is currently available in select practices in the UK and Ireland, with a broader rollout planned for Spring 2026 [5][1] - The product will be showcased at 100% Optical, the UK's largest optical event, to educate Eye Care Professionals about its technology and clinical benefits [5][1]